Epistaxis is a common emergency department (ED) presentation. Many cases are self-limited, but other cases may require an intervention to stop bleeding. Methods to manage epistaxis include nasal compression, topical vasoconstrictors, cautery, nasal packing, and even surgical ligation in severe cases.
What is the frequency of idiopathic epistaxis onset and its severity relative to the time of day?
Epistaxis may present early in HHT, but is typically mild in the pediatric period and is slightly worse in patients with HHT1.
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, often manifests with epistaxis.
Does bevacizumab delivered as a submucosal and topical intranasal therapy effectively control hereditary hemorrhagic telangiectasia (HHT)-associated epistaxis?